NRBO (NeuroBo Pharmaceuticals, Inc.) Dana dhuwit perusahaan

Logo korporat perusahaan NeuroBo (NRBO)

Intellectual property protection for molecules and high testing costs limit entry into the niche, while a stable R&D staff is supported by an Asian partnership. Cash dynamics at NeuroBo Pharmaceuticals (NRBO) demonstrate current liquidity, with the metric value standing at 0.03. The operational model of NeuroBo Pharmaceuticals (NRBO) relies on outsourcing production in the US and South Korea, eliminating the costs of maintaining its own plants.

NRBO - Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals Inc ing rentang 04.07.2022 - 07.12.2024

Ringkesan rincian data analitis NeuroBo (NRBO)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:NeuroBo NRBO
Produk merek NeuroBo Pharmaceuticals Inc

For biotech developer NeuroBo Pharmaceuticals (NRBO), liquidity levels determine the funding horizon for costly R&D research without relying on external borrowing. Daily monitoring of current cash reserves allows for an assessment of the burn rate and business sustainability prior to the commercialization of patents. This indicator measures operational resilience, eliminating the risk of asset degradation. A sufficient reserve guarantees the uninterrupted synthesis of molecules, confirming the company's ability to realize its potential for super-margins.

Pesaing wigati

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|ATXI - Cadangan dhuwit perusahaan|Volume dana dhuwit perusahaan BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Cadangan dhuwit perusahaan|CHRO: Dhuwit awis perusahaan|Eliem Therapeutics Inc. (ELYM) - Dhuwit awis perusahaan|Intra-Cellular Therapies Inc. (ITCI) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan NKGN (NKGen Biotech Inc)|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE